Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults
Clinical trial NCT04608630 · RECRUITING
Trial details
- NCT number
- NCT04608630
- Sponsor
- Australian and New Zealand Intensive Care Research Centre
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-15
- Primary completion
- 2027-02-28
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.